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Abstract
Background—The posterior ventral tegmental area (pVTA) mediates the reinforcing and 
stimulating effects of ethanol (EtOH). Electrophysiological studies indicated that exposure to 
EtOH increased glutamate synaptic function in the VTA. The current study determined the 
neurochemical effects of both acute and repeated EtOH exposure on glutamate neurotransmission 
in the pVTA.
Methods—Adult female Wistar rats were implanted with microdialysis probes in the pVTA. 
During microdialysis, rats received acute i.p. injection of saline or EtOH (0.5, 1.0 or 2.0 g/kg) and 
extracellular glutamate levels were measured in the pVTA. The effects of repeated daily injections 
of EtOH (0.5, 1.0, or 2.0 g/kg) on basal extracellular glutamate concentrations in the pVTA and on 
glutamate response to a subsequent EtOH challenge were also examined.
Results—The injection of 0.5 g/kg EtOH significantly increased (120–125 % of baseline), 
whereas injection of 2.0 g/kg EtOH significantly decreased (80% of baseline) extracellular 
glutamate levels in the pVTA. The dose of 1.0 g/kg EtOH did not alter extracellular glutamate 
levels. Seven repeated daily injections of each dose of EtOH increased basal extracellular 
glutamate concentrations (from 4.1 ± 0.5 to 9.2 ± 0.5 µM) and reduced glutamate clearance in the 
pVTA (from 30 ± 2% to 17 ± 2%), but failed to alter glutamate response to a 2.0 g/kg EtOH 
challenge.
Conclusion—The results suggest that the low dose of EtOH can stimulate the release of 
glutamate in the pVTA, and repeated EtOH administration increased basal glutamate transmission 
in the pVTA, as a result of reduced glutamate clearance.
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Introduction
The mesolimbic system projecting from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAC) is involved in the reinforcing and rewarding effects of ethanol (EtOH) 
(Koob and Volkow, 2010; McBride et al., 1999). Systemic administration of EtOH 
increased dopamine neuronal activity and dopamine levels in the VTA (Campbell et al., 
1996; Gessa et al., 1985). Inhibition of VTA dopamine neuronal activity reduced EtOH self-
administration (Hodge et al., 1993; Nowak et al., 2000). EtOH can be self-infused into the 
posterior VTA (pVTA) but not the anterior VTA (Rodd-Henricks et al., 2000; Rodd et al., 
2004). Similarly, EtOH stimulates mesolimbic dopamine neurons within the pVTA but not 
the anterior VTA (Ding et al., 2009b). Furthermore, the pVTA appeared to be a 
neuroanatomic site supporting EtOH seeking behavior (Hauser et al., 2011).
The VTA receives glutamatergic inputs from various brain regions and glutamate regulates 
the function of local dopamine neurons (Kalivas, 1993; White, 1996). A number of 
electrophysiological studies indicate that EtOH can alter VTA glutamate functions. For 
example, acute administration of EtOH, both in vivo and in vitro, inhibited NMDA receptor 
activity in the VTA (Allgaier et al., 1999; Steffensen et al., 2000). Both passive 
administration or chronic voluntary consumption of EtOH increased glutamate synaptic 
function onto VTA dopamine neurons, indicated by an increased ratio of evoked AMPAR to 
NMDAR currents (Saal et al., 2003; Stuber et al., 2008). Furthermore, chronic voluntary 
EtOH drinking enhanced the spontaneous glutamate release in VTA slices (Stuber et al., 
2008). Withdrawal from repeated injections of EtOH increased the probability of NMDA 
receptor-induced burst firing in VTA dopamine neurons (Hopf et al., 2007). At the 
molecular level, long-term EtOH exposure up-regulated the expression of the NMDA 
receptor NR1 subunit and the AMPA receptor GluR1 subunit in the VTA (Ortiz et al., 
1995). These findings indicate that VTA glutamate transmission plays an important role in 
the reinforcing effects of EtOH and EtOH self-administration.
Using microdialysis techniques, research has demonstrated the neurochemical effects of 
EtOH on the mesolimbic glutamate system. In the NAC, acute administration of EtOH 
produced biphasic changes of extracellular glutamate levels. In general, low to moderate 
doses of EtOH appeared to increase, whereas high doses of EtOH appeared to decrease 
extracellular glutamate levels in the NAC (Moghaddam and Bolinao, 1994; Piepponen et al., 
2002; Quertemont et al., 2002; Selim and Bradberry, 1996). In addition, chronic EtOH 
exposure enhanced basal extracellular glutamate levels in the NAC, as revealed with a 
conventional microdialysis technique (Dahchour and De Witte, 2000). Two studies utilizing 
quantitative no-net-flux (NNF) microdialysis also indicated increased basal extracellular 
glutamate concentrations in the NAC after repeated daily i.p. injections of EtOH in Sprague 
Dawley rats and C57BL/6J mice (Kapasova and Szumlinski, 2008; Melendez et al., 2005) 
These studies suggested an up-regulation of basal glutamate neurotransmission following a 
prior EtOH exposure. However, not all studies have observed such an increase (Goulding et 
al., 2011; Szumlinski et al., 2008). Furthermore, a history of EtOH exposure appears to alter 
the glutamate response to EtOH. A challenge injection of ethanol (1.5 – 2.0 g/kg) increased 
extracellular glutamate levels in the NAC in mice repeatedly treated with EtOH but had no 
effect in naïve mice (Kapasova and Szumlinski, 2008; Szumlinski et al., 2007).
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In contrast to the NAC, the neurochemical effects of EtOH on the glutamate system in the 
VTA have not been as well characterized. Given the important role of the pVTA in 
mediating the reinforcing and stimulating effects of EtOH (Ding et al., 2009b; Hauser et al., 
2011; Rodd-Henricks et al., 2000), the current study examined the effects of acute and 
repeated EtOH exposure on extracellular glutamate levels in the pVTA using microdialysis 
techniques. The hypothesis to be tested was that acute administration of ethanol would 
produce a dose-dependent increase on extracellular glutamate levels in the pVTA, and 
repeated daily i.p. injections of EtOH would increase basal extracellular glutamate 
concentrations in the pVTA and enhance glutamate response to a subsequent challenge 
injection of EtOH.
Methods and Materials
Animals
Adult female Wistar rats (weight 250 to 300 g, Harlan, Indianapolis IN, USA) were housed 
in pairs in temperature- and humidity-controlled rooms maintained on a reversed 12-hr light-
dark cycle (light on at 10:00 p.m.) with food and water available ad libitum. Female rats 
appear to maintain their head size better than male rats for more accurate stereotaxic 
placements and have been used in several studies requiring accurate placements (Ding et al., 
2009b, c; Rodd-Henricks et al., 2000). The estrous cycle was not monitored in the present 
study. However, counterbalanced experiments were conducted on different days so that any 
effect of a given phase of the estrous cycle was distributed across experimental conditions. 
All experimental procedures were conducted during the dark phase. Protocols were 
approved by the Institutional Animal Care and Use Committee of Indiana University School 
of Medicine. All experiments were conducted in accordance with principles outlined in the 
Guide for the Care and Use of Laboratory Animals (National Research Council, 1996).
Chemical agents
EtOH (190 proof) was obtained from McCormick Distilling, Weston, MO. O-
phthalaldehyde powder and diluents for glutamate derivatization were purchased from 
Pickering Laboratory, Inc, CA. The salts used in the aCSF and mobile phase were all HPLC 
grade and obtained from Sigma (St. Louis, MO, USA).
Cannula implantation and probe insertion
Rats were stereotaxically implanted with one 18-gauge guide cannula (Plastics One, Inc., 
Roanoke, VA, USA) aiming at the pVTA (AP −5.6 mm, ML +2.1 mm, DV −9.0 mm) 
(Paxinos and Watson, 1998). The cannula was implanted at a 10° angle to the vertical. Rats 
were individually housed following surgery, and were allowed to recover from surgery for at 
least 5 days and received daily habituation and handling in the microdialysis chambers. 
Following the recovery, microdialysis probes (active membrane length 1.5 mm, inner 
diameter 200 µm, molecular weight cut-off: 13,000, Spectrum Laboratories, Inc, Rancho 
Dominguez, CA, USA) were constructed (Benveniste and Huttemeier, 1990) and inserted 
into the pVTA approximately 16–18 hr before the microdialysis, as previously described 
(Ding et al., 2009a).
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Acute effects of i.p. injection of EtOH—General microdialysis followed the procedure 
described previously (Ding et al., 2009a). Briefly, rats were placed into microdialysis 
chambers and connected to a Harvard pump with PE20 tubing (inner diameter 0.38 mm, 
Becton Dickinson & Co., MD, USA). Microdialysis started with a 90-min wash-out period 
during which artificial cerebrospinal fluid (aCSF: 140.0 mM NaCl, 3.0 mM KCl, 1.2 mM 
CaCl2, 2.0 mM Na2HPO4·7H2O, 1.0 mM MgCl2, pH 7.2–7.4) was perfused through probes, 
followed by the collection of baseline samples. Then, rats were divided into four groups (n = 
6–8 / group) and each group received an i.p. injection of saline or one dose of EtOH (0.5, 1.0 
or 2.0 g/kg, 15% EtOH in saline). Six samples were collected thereafter. Samples were 
collected at 20-min intervals at a flow rate of 1.0 µl/min. Samples were frozen immediately 
on dry ice and were stored at −70°C before analysis.
A separate experiment examined the effects of Ca++ free aCSF on the 0.5 g/kg EtOH-
induced alteration of extracellular glutamate levels in the pVTA. Microdialysis started with 
the perfusion of Ca++ free aCSF (140.0 mM NaCl, 3.0 mM KCl, 2.0 mM Na2HPO4·7H2O, 
2.2 mM MgCl2, 1 mM EGTA, pH 7.2–7.4); baseline levels stabilized approximately 80 min 
after the perfusion of Ca++ free aCSF (see results on page 11). After the collection of three 
baseline samples, rats (n = 7) received i.p. injection of EtOH (0.5 g/kg) and six samples 
were collected following the EtOH injection.
Effects of repeated i.p. injections of EtOH—One experiment utilized the quantitative 
no-net-flux microdialysis technique to examine the effects of repeated i.p. injections of 
saline or EtOH (0.5, 1.0 or 2.0 g/kg) on basal extracellular glutamate concentrations in the 
pVTA. Approximately three to four days after surgery, rats (n = 6 – 8 /group) received daily 
i.p. injection of saline or EtOH for seven consecutive days. Microdialysis was conducted on 
the 8th day. During microdialysis, baseline samples were collected following the 90-min 
washout period. Then, four different concentrations of glutamate (1, 5, 10 or 20 µM in 
aCSF) were perfused through the pVTA in a random order. The glutamate concentrations in 
each perfusate were verified to be the stated concentrations on HPLC instruments before the 
perfusion by comparing the peak area of each concentration to the calibrated standard curve. 
Liquid swivels were employed to facilitate line switches between different concentrations of 
glutamate. Both the inlet and outlet of the collection assembly were constructed to allow a 
10-min lag time. The perfusion period for each concentration was 25 min after correcting for 
the lag time of the collection assembly. After the perfusion of the last glutamate 
concentration, the perfusion medium was changed to aCSF for 20 min. Samples were 
collected every five minutes at a flow rate of 2.0 µl/min.
Glutamate analysis
Glutamate was analyzed with a reversed-phase high performance liquid chromatography 
system with electrochemical detection, as described previously (Donzanti and Yamamoto, 
1988). Briefly, precolumn derivatization of glutamate with o-phthalaldehyde was performed 
using an ESA Model 542 autosampler. The mobile phase consisted of 25% methanol (v/v), 
100 mM Na2HPO4·7H2O, pH 6.75 and was delivered by an ESA 582 solvent delivery 
system. Dialysis samples were injected onto a reverse-phase column (BDS Hypersil C18 
Pioneer, 150 × 2 mm) and glutamate was separated and detected with a BAS LC-4C 
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amperometric detector with the oxidation potential set at +550 mV and the sensitivity set at 
0.2 µA. The outputs from the detector were sent to a ChromPerfect chromatography data 
analysis system. An external standard curve was constructed by calibrating with four 
concentrations of glutamate standards (1, 5, 10 and 20 µM). Briefly, each concentration of 
glutamate standard was injected into HPLC system three times and corresponding peak 
areas were recorded from resulting chromatograms. A linear regression curve plotted the 
peak areas against the concentrations of standards. The concentrations of glutamate in either 
samples or perfusates were quantified by comparing peak areas with the calibrated standard 
curve.
Histology
At the end of each experiment, rats were euthanized with an overdose of CO2 inhalation and 
1% bromophenol blue was then perfused through probes in the pVTA. Brains were removed 
quickly and frozen immediately on dry ice and stored at −20 °C. Sections (40 µm) were 
sliced on a cryostat microtome and stained with cresyl violet for verification of the 
placements of probes with reference to the rat brain atlas of Paxinos & Watson (1998).
Statistical analysis
For conventional microdialysis, the last three baseline samples were averaged and 
extracellular glutamate levels were normalized and expressed as percent of the baseline. 
ANOVAs with repeated measures on time were employed to analyze the normalized data 
demonstrating the time-course effects. If significant differences were detected with 
ANOVAs (p < 0.05), post-hoc tukey’s b tests were performed to determine the individual 
differences.
For no-net-flux microdialysis, data were analyzed with multiple linear regressions, as 
described previously (Parsons and Justice, 1994; Thielen et al., 2004). The glutamate 
concentrations (0, 1, 5, 10 and 20 µM) perfused through the probes were defined as [GLU]in, 
and the glutamate concentrations obtained from microdialysis samples were defined as 
[GLU]out. The net gain or loss of glutamate was defined as [Glu]in-[Glu]out and was 
calculated for each sample. These values of [GLU]in – [GLU]out were plotted as ‘y’ axis 
against the values of [GLU]in as ‘x’ axis. The slope (the extraction fraction, Ed) and the x-
intercept (the extracellular glutamate concentrations) for each group were determined by 
multiple linear regression modeling using the SAS System for Windows, version 8.02. 
Individual replicate data from all the animals in all groups were analyzed by ANOVA to 
compare the effect of EtOH on the slope and x-intercept.
Results
Histology
Fig. 1 shows the representative placements of probes in the pVTA. The pVTA is defined as 
the level of the interpeduncular nucleus from 5.3 mm to 6.0 mm posterior to bregma (Ding 
et al., 2009a; Rodd-Henricks et al., 2000). The correct placement for probes had to have at 
least 75% of the active membrane within the pVTA. Some probes also covered a small 
portion of the red nucleus to the dorsal side and a small portion of the interpeduncular 
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nucleus to the ventral side. Approximately 85% of animals fulfilled the criteria and were 
included in the analysis.
Effects of acute i.p. injection of EtOH
Extracellular glutamate levels in each group were: 3.3 ± 0.8 µM for the ‘saline’ group (n = 
8), 4.0 ± 1.6 µM for the ‘0.5 g/kg EtOH’ group (n = 8), 3.5 ± 0.7 µM for the ‘1.0 g/kg EtOH’ 
group (n = 8), and 3.5 ± 1.2 µM for the ‘2.0 g/kg EtOH’ group (n = 6). There were no 
significant differences in basal extracellular glutamate levels among these groups (F (3, 26) 
= 9.24, p = 0.97).
Figure 2 shows the time-course effects of i.p. injection of EtOH on extracellular glutamate 
levels. An overall “time” × “treatment” two-way ANOVA indicates that there are significant 
effects of time, treatment and time × treatment interaction (all F values > 1.79, all p values < 
0.05). The injection of either saline or 1.0 g/kg EtOH did not significantly alter extracellular 
glutamate levels (Fig 2A & 2C, p > 0.05). However, the injection of 0.5 g/kg EtOH 
significantly increased extracellular glutamate levels during the 20–60 min period to 
approximately 120–125% of the baseline levels (Fig 2B, p < 0.05). On the other hand, the 
injection of 2.0 g/kg EtOH significantly decreased extracellular glutamate levels during the 
80–120 min period to approximately 80% of the baseline levels (Fig 2D, p < 0.05). In 
addition, perfusion of the pVTA with the Ca++ free aCSF prevented the 0.5 g/kg EtOH-
induced increase of extracellular glutamate levels (Fig 2B, F (1,13) = 11.6, p < 0.01)
A separate experiment (n = 10) examined the effects of perfusion with the Ca++ free aCSF 
on basal extracellular glutamate levels in the pVTA (data not shown). After the perfusion 
medium was changed to Ca++ free aCSF, extracellular glutamate levels were reduced and 
significant reduction occurred approximately 80 min after the change of the perfusion 
medium and remained reduced throughout the end of the perfusion (180 min, F (14, 126) = 
2.22, p < 0.05). The average extracellular glutamate levels during this period (80 – 180 min) 
were 80 ± 5% of baseline levels. Extracellular glutamate levels returned to baseline levels 
following the change of the perfusion medium back to Ca++ containing aCSF.
Effects of repeated daily injections of EtOH
Figure 3 shows the results from the no-net-flux experiments. Multiple linear regression lines 
plotting [GLU]in – [GLU]out as ‘y’ axis and [GLU]in as ‘x’ axis were shown in Figure 3A. 
Extracellular glutamate concentrations, as represented by the x-intercept of each line, were: 
4.1 ± 0.5 µM for the ‘saline’ group, 6.6 ± 0.4 µM for the ‘0.5 g/kg EtOH’ group, 6.7 ± 0.4 
µM for the ‘1.0 g/kg EtOH’ group, and 9.2 ± 0.5 µM for the ‘2.0 g/kg EtOH’ group (Figure 
3B). ANOVA revealed a significant effect of treatment (F (3, 390) = 6.59, p < 0.001). 
Repeated i.p. injections of each dose of EtOH significantly increased extracellular glutamate 
concentrations in the pVTA compared to repeated saline injections (p < 0.05). In addition, 
the extracellular glutamate concentrations in the ‘2.0 g/kg EtOH’ group were significantly 
higher than those in all other groups (p < 0.05).
The extraction fractions (Eds) as represented by the slope of each line in each group were: 
30 ± 2% for the ‘saline’ group, 22 ± 2% for the ‘0.5 g/kg EtOH’ group, 17 ± 2% for the ‘1.0 
g/kg EtOH’ group, and 20 ± 2% for the ‘2.0 g/kg EtOH’ group (Figure 3C). ANOVA 
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revealed a significant effect of treatment (F (3, 387) = 9.20, p < 0.001). Further analysis 
indicated that repeated i.p. injections of each dose of EtOH significantly reduced Ed values 
in the pVTA compared to those in the ‘saline’ group (p < 0.05). The Ed values in three 
EtOH-treated groups were not significantly different from one another (p > 0.05).
The experiment examining pVTA glutamate response to a challenge dose of EtOH 
following 7-day repeated EtOH injections used the dose of 2.0 g/kg EtOH for both 
pretreatment and challenge, as suggested by the greatest effect of this dose of EtOH in the 
NNF study (Fig. 3). Basal extracellular glutamate levels were 3.0 ± 0.9 µM for saline-
pretreated rats (n=6) and 3.8 ± 1.4 µM for EtOH-pretreated rats (n = 5). During the 
microdialysis, rats in both pretreatment groups received a challenge injection of saline 
followed by an injection of 2.0 g/kg EtOH. Since the effects of the challenge injections were 
similar for both pretreatment groups, the data were combined and presented in Fig. 4. The 
repeated measures ANOVA revealed a significant effect of time (F (18, 180) = 4.26, p < 
0.001). The injection of saline did not significantly alter extracellular glutamate levels. In 
contrast, the injection of 2.0 g/kg EtOH reduced extracellular glutamate (p < 0.05) to levels 
previously observed following i.p. injection of 2.0 g/kg EtOH in animals that had not 
received any pretreatment (Fig. 2D).
Discussion
The results of the current study indicate that both acute and chronic EtOH exposure altered 
extracellular glutamate transmission in the pVTA. Acute systemic administration of EtOH 
produced a biphasic effect on extracellular glutamate levels in the pVTA. Ca++ free aCSF 
prevented the increase of extracellular glutamate levels in the pVTA induced by the low 
dose of EtOH, suggesting that the low dose of EtOH may act, at least in part, through 
increasing Ca++ dependent release of glutamate. Furthermore, repeated systemic 
administrations of EtOH increased basal extracellular glutamate concentrations and reduced 
Ed values in the pVTA, suggesting that repeated EtOH exposure produced adaptive changes 
in the pVTA glutamate system, resulting in decreased glutamate clearance and increased 
extracellular glutamate concentrations. However, repeated injections of EtOH did not appear 
to alter subsequent glutamate response to a challenge dose of EtOH.
It has been shown that EtOH produced a biphasic effect on extracellular glutamate levels in 
the NAC of rats (Moghaddam and Bolinao, 1994). Similarly, the current study demonstrated 
that systemic administration of EtOH also produced biphasic alteration of extracellular 
glutamate levels in the pVTA (Fig. 2). In the Moghadddam & Bolinao (1994) study, 0.5 
g/kg EtOH increased extracellular glutamate levels in the NAC to over 250% of the 
baseline, whereas the current study indicated only a moderate increase in the pVTA, i.e., to 
approximately 120–125% of the baseline (Fig. 2B). These results suggest that NAC may be 
more responsive to the excitatory effects of EtOH on extracellular glutamate than the pVTA. 
In both the NAC and pVTA, 2.0 g/kg EtOH appeared to induce a similar delayed reduction 
of extracellular glutamate levels (Moghaddam and Bolinao, 1994, Fig. 2D), suggesting that 
extracellular glutamate in both regions may be similarly responsive to the inhibitory effect 
of EtOH. The injection of 1.0 g/kg EtOH did not significantly alter extracellular glutamate 
levels in the pVTA, which is consistent with one recent study (Kemppainen et al., 2010). 
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However, the Kemppainen et al. study (2010) also did not find any effect with the i.p. 
injection of 2.0 g/kg EtOH. The different findings may be due to different rat strains used 
between these two studies. Indeed, several studies indicated that different strains of rats 
responded differently to EtOH with regard to changes in the extracellular glutamate levels in 
the NAC (Piepponen et al., 2002; Quertemont et al., 2002; Selim and Bradberry, 1996; Yan 
et al., 1998). Furthermore, the lack of significant changes with 2.0 g/kg EtOH in the 
Kemppainen et al. study (2010) may be due to the observed response of extracellular 
glutamate to saline. In that study, saline injection produced an approximately 30% reduction 
of VTA extracellular glutamate levels, which may have prevented observing any decrease in 
extracellular glutamate levels with the injection of 2.0 g/kg EtOH.
In addition, the current study indicated that perfusion with the Ca++ free aCSF through the 
pVTA significantly reduced basal extracellular glutamate levels to approximately 80% of 
the baselines, suggesting that approximately 20% of basal extracellular glutamate levels 
sampled with microdialysis may be coming from Ca++ dependent release. The results are 
consistent with a previous study indicating that blockade of the N-type Ca++ channel in the 
NAC significantly reduced local extracellular glutamate levels by 30% (Baker et al., 2002). 
Similar findings were also reported in the striatum (Morari et al., 1993). However, recent 
evidence suggests that astrocytes can release glutamate in a calcium-dependent manner 
(Reyes and Parpura, 2009). Therefore, it is possible that Ca++ depletion in the current study 
may also reduce glutamate released from astrocytes.
Low to moderate doses of EtOH have been shown to increase extracellular glutamate levels 
in various brain regions, including the NAC and hippocampus (Moghaddam and Bolinao, 
1994; Selim and Bradberry, 1996). The present findings with acute low dose EtOH are in 
agreement with the results obtained in the NAC and hippocampus. In vitro 
electrophysiological studies performed on VTA slices and isolated VTA neurons also 
indicated that acute exposure to low concentrations of EtOH increased glutamate release in 
the VTA, involving a dopamine D1 receptor mechanism (Deng et al., 2009; Xiao et al., 
2009). Further studies will be needed to determine whether systemic administration of EtOH 
is acting on glutamate terminals within the pVTA and/or brain regions projecting to the 
pVTA, e.g. the laterodorsal and pedunculopontine tegmental nuclei.
The mechanisms underlying the reduction of extracellular glutamate levels by 2.0 g/kg 
EtOH were not explored in the current study. One previous study (Yan et al., 1998) 
demonstrated that acute injection of 2.0 g/kg EtOH attenuated high K+ induced synaptic 
release of glutamate in the NAC, suggesting that 2.0 g/kg EtOH may reduce synaptic release 
of glutamate in the NAC. Similar mechanisms may also underlie the effect of this dose of 
EtOH in the pVTA. EtOH may exert its effects through areas projecting to the pVTA and/or 
locally within the pVTA. For example, ethanol has been shown to inhibit persistent activity 
in the medial prefrontal cortex, a region that sends glutamate projections to both the VTA 
and NAC (Tu et al., 2007).
Repeated EtOH exposure increased basal extracellular glutamate concentrations and reduced 
Ed values in the pVTA compared to the saline treatment (Figure 3B). The results are 
consistent with previous no-net-flux microdialysis studies in the NAC of both rats (1.0 g/kg) 
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and mice (2.0 g/kg) using similar repeated injection paradigms (Kapasova and Szumlinski, 
2008; Melendez et al., 2005). These results suggest that repeated EtOH exposure reduced 
extracellular glutamate clearance, leading to increased basal extracellular glutamate 
concentrations. However, the current findings do not exclude a possible increase of basal 
glutamate release in the VTA following repeated EtOH treatment. Chronic EtOH exposure 
has been shown to increase spontaneous glutamate release in the VTA (Stuber et al., 2008), 
which could contribute to enhanced basal extracellular glutamate concentrations observed in 
the current study. Furthermore, 2.0 g/kg EtOH induced a greater increase in the extracellular 
glutamate concentrations compared to the two lower doses, but there was no difference in 
glutamate clearance among the 3 doses. These results suggest that an additional increase of 
glutamate release may contribute to the effects of the highest dose of EtOH.
Following 7 daily repeated injections of EtOH, a challenge dose of 2.0 g/kg EtOH produced 
an approximately 20% of reduction in extracellular glutamate levels in the pVTA, similar to 
the effects examined in the acute injection study (Fig. 2D). This finding is different from the 
predication based on findings from the NAC (Kapasova and Szumlinski, 2008; Szumlinski 
et al., 2007), which indicated significantly greater increases of NAC glutamate levels 
induced by a challenge injection of EtOH following a period of EtOH exposure. Different 
brain regions examined may account for this difference. These findings suggest that the 
NAC may be more responsive to EtOH than the pVTA in rats with a history of EtOH 
exposure.
Extracellular glutamate is mainly cleared by re-uptake mechanisms maintained by 
membrane glutamate transporters (Danbolt, 2001). Therefore, it is possible that repeated 
EtOH treatment may down-regulate glutamate transporter function by either decreasing the 
density of the transporters and/or by modifying transporter activities. The study of Melendez 
et al (2005) indicated that seven daily injections of 1.0 g/kg EtOH reduced Na+ dependent 
glutamate uptake in an in vitro assay, but did not alter protein levels of two major glutamate 
transporters, suggesting that repeated EtOH may alter the post-translational modifications of 
glutamate transporters in the NAC, e.g., phosphorylation. Reduced glutamate transporter 
function was also reported in other studies with different EtOH exposure paradigms. 
Glutamate uptake activity was reduced in the cerebral cortex of alcohol-preferring cAA rats 
following voluntary drinking of EtOH for 20 months compared to that in alcohol naïve cAA 
rats (Schreiber and Freund, 2000). Incubation of rat cortical cells with 50–100 mM EtOH for 
6 hr produced significant a 10–15% reduction of glutamate uptake and led to approximately 
a 70% increase of glutamate in the incubation medium (Singh et al., 1994).
The increased glutamate transmission following either acute or repeated injections of low to 
moderate doses of EtOH may have significant functional implications. For example, the 
increased extracellular glutamate levels in the pVTA following acute injection of the low 
dose of EtOH may contribute to EtOH induced behavioral stimulation and increase of 
extracellular dopamine in the NAC (Imperato and Di Chiara, 1986). In addition, the 
increased basal extracellular glutamate concentrations in the pVTA following repeated 
injections of EtOH may contribute to increased basal extracellular dopamine concentrations 
in the NAC (Smith and Weiss, 1999). Given the importance of the mesolimbic dopamine 
transmission in the positive reinforcement of EtOH, the increased glutamate 
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neurotransmission in the pVTA, therefore, may contribute to the reinforcing effects of 
EtOH.
In summary, the current study demonstrated that acute injection of EtOH produces a 
biphasic effect on extracellular glutamate levels in the pVTA. Repeated EtOH exposure 
reduced clearance of extracellular glutamate, leading to increased basal extracellular 
glutamate concentrations in the pVTA. These changes may be involved in mediating the 
reinforcing and rewarding effects of EtOH.
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Figure 1. 
Representative placements of microdialysis probes in the posterior ventral tegmental area 
(pVTA). The pVTA was determined based on previous findings (Ding et al., 2009b; Rodd-
Henricks et al., 2000). Overlapping probes are not shown for clarity purposes. The lines 
represent the 1.5-mm active length of the microdialysis membrane.
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Figure 2. 
Time-course effects of intraperitoneal injection of saline or EtOH (0.5, 1.0 or 2.0 g/kg) on 
extracellular glutamate levels in the posterior ventral tegmental area during perfusion with 
normal aCSF, or in the case of 0.5 g/kg EtOH, during perfusion with aCSF or Ca++ free 
aCSF. *, p < 0.05, significantly different from the baseline level; #, p < 0.05, significantly 
from the ‘saline’ group; +, p < 0.05, significantly different from the ‘saline’ and ‘0.5 g/kg 
EtOH/Ca++ free aCSF’ groups.
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Figure 3. 
Effects of repeated daily i.p. injections of saline or EtOH (0.5, 1.0 or 2.0 g/kg) for 7 
consecutive days on extracellular glutamate concentrations and extraction fractions (Eds) in 
the posterior ventral tegmental area. A) linear regression plots of glutamate for the saline, 
0.5, 1.0 and 2.0 g/kg EtOH groups; B) extracellular glutamate concentrations determined 
from points of no-net-flux; C) Ed values of glutamate determined from the slope of the plots 
for the linear regression analysis. *, p < 0.05, significantly higher than the ‘saline’ group. #, 
p < 0.05, significantly higher than all other groups.
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Figure 4. 
Effects of i.p. injection of saline and 2.0 g/kg EtOH in rats pretreated for 7 days with daily 
injections of either saline (n = 6) or 2.0 g/kg EtOH (n = 5). Since the challenge injections 
produced similar effects in both groups, the data from two groups were combined. * p < 
0.05, significantly lower than baseline levels.
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